Related Experiment Video
Updated: Oct 19, 2025
05:19
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
10.5K
[Molecular diagnostics of bladder cancer-practical ramifications].
Gerald B Schulz1, Christian G Stief1, Matthias Saar2,3
1Urologische Klinik und Poliklinik, Klinikum der Universität München (LMU), München, Deutschland.
Der Urologe. Ausg. A
|September 22, 2021
Summary
Precision medicine targeting genetic alterations is crucial for bladder cancer treatment. Molecular diagnostics on tumor samples guide therapy choices and clinical trial enrollment.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Precision medicine is emerging as a key strategy in bladder cancer management.
- Targeting specific genetic alterations offers new therapeutic avenues.
Purpose of the Study:
- To highlight the role of molecular diagnostics in guiding bladder cancer treatment decisions.
- To discuss the integration of molecular profiling into clinical practice.
Main Methods:
- Analysis of formalin-fixed paraffin-embedded tumor samples for genetic alterations.
- Discussion of molecular findings in interdisciplinary molecular tumor boards.
Main Results:
- Molecular analyses identify actionable targets for approved therapies or clinical trials.
- These approaches are valuable for patients with limited therapeutic options or rare subtypes.
Conclusions:
- Precision medicine, guided by molecular diagnostics, is essential for future bladder cancer care.
- Interdisciplinary molecular tumor boards are critical for treatment recommendations and patient management.
